Caricamento...
Interference of HCV replication by cell penetrable human monoclonal scFv specific to NS5B polymerase
A new class of hepatitis C virus (HCV)-targeted therapeutics that is safe, broadly effective and can cope with virus mutations is needed. The HCV's NS5B is highly conserved and different from human protein, and thus it is an attractive target for anti-HCV therapeutics development. In this study...
Salvato in:
| Pubblicato in: | MAbs |
|---|---|
| Autori principali: | , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Taylor & Francis
2014
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4622650/ https://ncbi.nlm.nih.gov/pubmed/25517317 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/mabs.29978 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|